Dose Titration of Propofol for Tracheal Intubation in Children With Sevoflurane Inhalation Induction

NCT ID: NCT01084031

Last Updated: 2014-02-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

50 participants

Study Classification

INTERVENTIONAL

Study Start Date

2009-11-30

Study Completion Date

2011-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Dose titration of propofol for tracheal intubation in children with sevoflurane inhalation induction.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pediatric Urinary Disorders

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

propofol

Group Type EXPERIMENTAL

propofol

Intervention Type DRUG

intravenous propofol with sevoflurane inhalation induction

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

propofol

intravenous propofol with sevoflurane inhalation induction

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Pediatric patients scheduled for elective day case surgery were enrolled.

Exclusion Criteria

* History of obstructive sleep apnea
* Evidence of cardiorespiratory disease
* Those who were obese or allergic to any of the anesthetic agents in this study
* Those with an anticipated difficult airway, full stomach
* History of malignant hyperthermia or other myopathy were excluded.
Minimum Eligible Age

6 Months

Maximum Eligible Age

5 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Yonsei University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Hae Keum Kil

Role: PRINCIPAL_INVESTIGATOR

Department of Anesthesiology and Pain Medicine, Yonsei University College of Medicine, Seoul, Korea

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

4-2009-0470

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Ketamine and Propofol for Upper Endoscopy
NCT02295553 COMPLETED PHASE4